Preferred Buyer Location All Countries Except India
Osimertinib is indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, whose disease has progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.
Member Since 11 Years
Nature of Business Exporter
GST No. 27AAIFC5596P1ZK
For Buyer 
For Seller 
Help 
Abhyankar Nagar, Nagpur, Maharashtra